Tumor-derived EVs that contain miR-203 can inhibit DC maturation via the downregulation of the expression of TLR-4 and Tumor Necrosis Factor alpha (TNF-α), impairing the capacity to mediate IL-12-dependent Th1 differentiation [97]. The gene discussed is TLR4; the disease is neoplasm.